Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune study

Wharton’s Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent Findings and Clinical Significance

(2015) Ilona Kalaszczynska et al.   Biomed Research International

Mesenchymal Stromal Cell Therapy for Cardio Renal Disorders

(2014) Marlies Reinders et al.   CURRENT PHARMACEUTICAL DESIGN

Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients

(2014) Marlies EJ Reinders et al.   Journal of Translational Medicine

Impact of Aging on the Regenerative Properties of Bone Marrow-, Muscle-, and Adipose-Derived Mesenchymal Stem/Stromal Cells

(2014) Olivia S. Beane et al.   PLoS One

Impact of Cotransplantation of Mesenchymal Stem Cells on Lung Function After Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Following Non-Myeloablative Conditioning

(2014) Catherine Moermans et al.   TRANSPLANTATION

Protein synthesis and secretion in human mesenchymal cells derived from bone marrow, adipose tissue and Wharton’s jelly

(2014) Paola Amable et al.   Stem Cell Research & Therapy

Autologous and allogeneic mesenchymal stem cells in organ transplantation

(2013) Senthilkumar Alagesan et al.   Current Opinion in Organ Transplantation

Mesenchymal stromal cells to prevent fibrosis in kidney transplantation

(2013) Marlies E.J. Reinders et al.   Current Opinion in Organ Transplantation

Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy

(2013) Marlies E.J. Reinders et al.   CYTOTHERAPY

Antibody-mediated rejection, T cell–mediated rejection, and the injury-repair response: new insights from the Genome Canada studies of kidney transplant biopsies

(2013) Philip F. Halloran et al.   KIDNEY INTERNATIONAL

Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival

(2013) Alexandre Loupy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mesenchymal Stem Cells Induce an Inflammatory Response After Intravenous Infusion

(2013) Martin J. Hoogduijn et al.   STEM CELLS AND DEVELOPMENT

Mesenchymal stromal cells and kidney transplantation: pretransplant infusion protects from graft dysfunction while fostering immunoregulation

(2013) Norberto Perico et al.   TRANSPLANT INTERNATIONAL

The Role of Immunoglobulin-G Subclasses and C1q in De Novo HLA-DQ Donor-Specific Antibody Kidney Transplantation Outcomes

(2013) Maria Cecilia S. Freitas et al.   TRANSPLANTATION

Mesenchymal Stem Cells in Solid Organ Transplantation (MiSOT) Fourth Meeting

(2013) Marcella Franquesa et al.   TRANSPLANTATION

Incidence and Impact of De Novo Donor-Specific Alloantibody in Primary Renal Allografts

(2013) Matthew J. Everly et al.   TRANSPLANTATION

Heart Grafts Tolerized Through Third-Party Multipotent Adult Progenitor Cells Can Be Retransplanted to Secondary Hosts With No Immunosuppression

(2013) Elke Eggenhofer et al.   Stem Cells Translational Medicine

Autologous Bone Marrow-Derived Mesenchymal Stromal Cells for the Treatment of Allograft Rejection After Renal Transplantation: Results of a Phase I Study

(2013) Marlies E.J. Reinders et al.   Stem Cells Translational Medicine

Evolution and Clinical Pathologic Correlations of De Novo Donor-Specific HLA Antibody Post Kidney Transplant

(2012) C. Wiebe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

The impact of mesenchymal stem cell therapy in transplant rejection and tolerance

(2012) Marcella Franquesa et al.   Current Opinion in Organ Transplantation

Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?

(2012) Matthew D Griffin et al.   IMMUNOLOGY AND CELL BIOLOGY

Induction Therapy With Autologous Mesenchymal Stem Cells in Living-Related Kidney Transplants

(2012) Jianming Tan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy

(2012) Joshua M. Hare et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mesenchymal Stem Cell Therapy Prevents Interstitial Fibrosis and Tubular Atrophy in a Rat Kidney Allograft Model

(2012) Marcella Franquesa et al.   STEM CELLS AND DEVELOPMENT

De Novo DQ Donor-Specific Antibodies Are Associated With a Significant Risk of Antibody-Mediated Rejection and Transplant Glomerulopathy

(2012) Michelle Willicombe et al.   TRANSPLANTATION

Donor-Derived Mesenchymal Stem Cells Combined With Low-Dose Tacrolimus Prevent Acute Rejection After Renal Transplantation

(2012) Yanwen Peng et al.   TRANSPLANTATION

Detrimental effects of rat mesenchymal stromal cell pre-treatment in a model of acute kidney rejection

(2012) Martina Seifert et al.   Frontiers in Immunology

Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal

(2010) K. E. Lamb et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Autologous Mesenchymal Stromal Cells and Kidney Transplantation: A Pilot Study of Safety and Clinical Feasibility

(2010) N. Perico et al.   Clinical Journal of the American Society of Nephrology

Concise Review: Hitting the Right Spot with Mesenchymal Stromal Cells

(2010) Jakub Tolar et al.   STEM CELLS

Evidence for Antibody-Mediated Injury as a Major Determinant of Late Kidney Allograft Failure

(2010) Robert S. Gaston et al.   TRANSPLANTATION

C1q-Fixing Human Leukocyte Antigen Antibodies Are Specific for Predicting Transplant Glomerulopathy and Late Graft Failure After Kidney Transplantation

(2010) Julie M. Yabu et al.   TRANSPLANTATION

Infusion of Mesenchymal Stem Cells and Rapamycin Synergize to Attenuate Alloimmune Responses and Promote Cardiac Allograft Tolerance

(2009) W. Ge et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antibody-Mediated Microcirculation Injury Is the Major Cause of Late Kidney Transplant Failure

(2009) G. Einecke et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Measured GFR as a Confirmatory Test for Estimated GFR

(2009) L. A. Stevens et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Human Leukocyte Antigen Antibodies and Chronic Rejection: From Association to Causation

(2009) Paul I. Terasaki et al.   TRANSPLANTATION

Anti-Human Leukocyte Antigen and Donor-Specific Antibodies Detected by Luminex Posttransplant Serve as Biomarkers for Chronic Rejection of Renal Allografts

(2009) Nils Lachmann et al.   TRANSPLANTATION

Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model

(2008) Paolo Sbano et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

HLA-Mismatched Renal Transplantation without Maintenance Immunosuppression

(2008) Tatsuo Kawai et al.   NEW ENGLAND JOURNAL OF MEDICINE

Autologous and Allogeneic Marrow Stromal Cells Are Safe and Effective for the Treatment of Acute Kidney Injury

(2008) Florian Tögel et al.   STEM CELLS AND DEVELOPMENT

Age-related changes in human bone marrow-derived mesenchymal stem cells: Consequences for cell therapies

(2007) A. Stolzing et al.   MECHANISMS OF AGEING AND DEVELOPMENT